Antibody persistence following booster vaccination against tick-borne encephalitis: 3-Year post-booster follow-up

Vaccine

Volumn 25, Issue 27, 2007, Pages 5097-5101

  Rendi Wagner, Pamela ^a,b   Paulke Korinek, Maria ^a   Kundi, Michael ^a   Wiedermann, Ursula ^a,b   Laaber, Brigitte ^b   Kollaritsch, Herwig ^a,b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Center for Travel Medicine   (Austria)

Author keywords

Antibody persistence; Booster interval; Long term follow up; Low responsiveness; Tick borne encephalitis; Vaccination

Indexed keywords

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; CONFIDENCE INTERVAL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; IMMUNIZATION; KINETICS; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SERODIAGNOSIS; TICK BORNE ENCEPHALITIS; VACCINATION;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; ENCEPHALITIS VIRUSES, TICK-BORNE; ENCEPHALITIS, TICK-BORNE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNIZATION, SECONDARY; KINETICS; LOGISTIC MODELS; MALE; MIDDLE AGED; NEUTRALIZATION TESTS; REGRESSION ANALYSIS; VACCINATION;

EID: 34249940061     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.01.116     Document Type: Article

References (16)

1. Virus Epidemiologische Information. Nr. 02/06. Institut für Virologie der Medizinischen Universität Wien. http://www.univie.ac.at/virologie/cms/; accessed December 1, 2006.
2. Kunz C. TBE vaccination and the Austrian experience. Vaccine 21 Suppl 1 (2003) 50-55
3. Rendi-Wagner P., Kundi M., Zent O., Dvorak G., Jaehnig P., Holzmann H., et al. Persistence of protective immunity following vaccination against tick-borne encephalitis-longer than expected?. Vaccine 22 21-22 (2004) 2743-2749
4. Rendi-Wagner P., Kundi M., Zent O., Banzhoff A., Jaehnig P., Stemberger R., et al. Immunogenicity and safety of a booster vaccination against tick-borne encephalitis more than 3 years following the last immunisation. Vaccine 23 4 (2004) 427-434
5. Klockmann U., Block H., Kwasny H., Praus M., Cihlova V., Tomkova E., et al. Humoral immunity against tick-borne encephalitis virus following manifest disease and active immunization. Vaccine 9 1 (1991) 42-46
6. Kaiser R., and Holzmann H. Laboratory findings in tick-borne encephalitis-correlation with clinical outcome. Infection 28 (2000) 78-84
7. Holzmann H., Kundi M., Stiasny K., Clement J., McKenna P., Kunz C., et al. Correlation between ELISA; hemagglutination inhibition, and neutralization test after vaccination against tick-borne encephalitis. J Med Virol 48 (1996) 102-107
8. Putz M.M., Alberini I., Midgley C.M., Manini I., Montomoli E., and Smith G.L. Prevalence of antibodies to Vaccinia virus after smallpox vaccination in Italy. J Gen Virol 86 (2005) 2955-2960
9. Crotty S., Felgner P., Davies H., Glidewell J., Villarreal L., and Ahmed R. Cutting edge: long-term B cell memory in humans after smallpox vaccination. J Immunol 171 (2003) 4969-4973
10. Lanzavecchia A., Bernasconi N., Traggiai E., Ruprecht C.R., Corti D., and Sallusto F. Understanding and making use of human memory B cells. Immunol Rev 211 (2006) 303-309
11. Vene S., Haglund M., Lundkvist A., Lindquist L., and Forsgren M. Study of the serological response after vaccination against tick-borne encephalitis in Sweden. Vaccine 25 2 (2007) 366-372
12. Zent O., Plentz A., Schwarz T.F., Fruhwein N., Kuhr H.B., Broeker M., et al. TBE booster immunization according to the rapid immunization schedule: are 3-year booster intervals really necessary?. Vaccine 23 3 (2004) 312-315
13. Beran J., Douda P., Gniel D., and Zent O. Long-term immunity after vaccination against tick-borne encephalitis with Encepur using the rapid vaccination schedule. Int J Med Microbiol 293 Suppl 37 (2004) 130-133
14. Rendi-Wagner P., Kundi M., Stemberger H., Wiedermann G., Holzmann H., Hofer M., et al. Antibody-response to three recombinant hepatitis B vaccines: comparative evaluation of multicenter travel-clinic based experience. Vaccine 19 (2001) 2055-2060
15. Alper C.A., Kruskall M.S., Marcus-Bagley D., Craven D.E., Katz A.J., and Brink S.J. Genetic prediction of non-response to hepatitis B vaccine. N Engl J Med 321 (1989) 708-712
16. Hollinger F.B. Factors influencing the immune response to hepatitis B vaccine, booster dose guidelines, and vaccine protocol recommendations. Am J Med 87 Suppl 3A (1989) 36S-40S